A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
about
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusTargeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusLow glycaemic index, or low glycaemic load, diets for diabetes mellitusAlpha-glucosidase inhibitors for type 2 diabetes mellitusEffect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trialsNephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomesTreating the elderly diabetic patient: special considerationsDiabetes: glycaemic control in type 2.Combined use of basal insulin analog and acarbose reduces postprandial glucose in patients with uncontrolled type 2 diabetes.The use of low-glycaemic index diets in diabetes control.Effects of the alpha-glucosidase inhibitor acarbose on the development of long-term complications in diabetic animals: pathophysiological and therapeutic implications.Glucose supply and insulin demand dynamics of antidiabetic agents.Pharmacotherapy of type 2 diabetes mellitus.Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trialsThe importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus.Evaluation of the efficacy and tolerability of miglitol in Chinese patients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas.Diabetes: glycaemic control in type 2 (drug treatments).The effect of polyhydroxylated alkaloids on maltase-glucoamylase"Low dose" metformin improves hyperglycemia better than acarbose in type 2 diabetics.Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetesInfluence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study.Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations.A randomized clinical trial comparing low-glycemic index versus ADA dietary education among individuals with type 2 diabetes.Comparative safety of newer oral antidiabetic drugs.An observational study of acarbose treatment in patients with type 2 diabetes from the Middle East and MoroccoAcarbose: oral anti-diabetes drug with additional cardiovascular benefits.Metformin therapy and clinical uses.Production and Characterization of a New α-Glucosidase Inhibitory Peptide from Aspergillus oryzae N159-1.Hypoglycemic Effect of Padina arborescens Extract in Streptozotocin-induced Diabetic Mice.Diabetes medications and body weight.The glycemic index: physiological significance.On the potential of acarbose to reduce cardiovascular disease.α-glucosidase inhibitors from plants: A natural approach to treat diabetes.A review of the efficacy and safety of oral antidiabetic drugsFiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials.Comparative evaluation of incretin-based antidiabetic medications and alternative therapies to be added to metformin in the case of monotherapy failure.
P2860
Q24186667-42248B77-9E52-4C55-8F00-6153E0EF85D8Q24202505-57FB95DE-85DE-4104-804A-BD7031D3E5E1Q24235718-0B9718FD-B5A8-4A8A-8A83-19238D368524Q24236456-B878E3E2-4654-462A-8146-C753BF76F8B5Q24240522-FF18C1F1-9CA9-465F-8B1E-DBAFAACC3E76Q24241460-9661B496-42DA-45F1-9A4F-B28C96D51235Q24246908-E70A1C33-D2DE-4321-9421-0C2F90D4EE27Q24628988-6D4EF00B-7504-4793-BBB2-B206384C2D85Q26777994-ECAFF1A2-C157-4B86-9050-254454D088D3Q26778095-E31E8B08-6B54-43C8-A557-0B763DE3AD0EQ26995176-3104CF78-FF30-4294-ADD6-745F62F1C068Q33446693-D9B4971D-EC68-4386-B578-45EF7CEBCF58Q33464541-C04469F1-F7D2-420F-97FB-0CA08DDE0E12Q33565079-F86FE323-7F2E-4A6A-83A5-A5ABF2A802ABQ33737758-A3309FE7-A615-464B-9520-3B68AA7C35E5Q33828255-8170D7E2-F3C1-4352-A1E1-B54920F3526AQ33992531-0EBDE12D-7264-489C-973E-9FF500BEBB24Q34083400-A720C1A5-9981-4D92-82EA-4746646B3052Q34292419-2CC25264-C331-4C47-8B6B-A5C01EDB8456Q34623166-CE30BA19-8A86-4872-9FCA-58CF15734C05Q34829290-5ECCDF88-B1C6-4EBC-937A-883B5AD98125Q34962981-B07287AC-5D52-4210-A807-8C6979903EF2Q35612646-296C1222-A505-4A91-BD94-AC7CF2E4EC49Q36088468-798D980A-87DC-4D3E-A3A7-6A3F4899C4ECQ36316219-7CB525AB-9782-4729-854D-1015E6D309F3Q36333089-C22B6ACF-3E78-4E79-A75C-9D7DFD7B19ACQ36580294-70F799CF-4856-42C9-92EF-5AF44DAA29E4Q36624990-989E0688-7D5A-4AAB-A1B8-489753F4D2BCQ36766197-578957FD-6418-4E8E-9870-AB4BACDB106BQ37076275-17192DF1-0A6B-4883-8BE1-EE9D14487EC6Q37262966-94EAD85E-76E1-46BC-BC5E-84285DF6654AQ37279031-968B016E-942B-431B-84F8-FD6A7C6B04BCQ37400463-5C433812-F582-472E-856A-ED02189F0AB7Q37524006-6F9E605A-0167-46B0-A602-2F3C0266F4F4Q37710264-F6532C00-FB36-4D2B-A4C3-C8D29A279A22Q37717838-DC16096E-B1C7-4D40-A859-96518C13C08EQ37957853-CE6B244E-4467-4FB2-BA2B-AA5EDB44E7FEQ38067491-E967A357-A564-4AC4-AC05-DA0910A78E39Q38158229-59FBCBF2-5518-458F-9233-FBB6DFF05173Q38213037-F8E30914-DB91-41BC-9BFB-7BB6A1236140
P2860
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A randomized double-blind tria ...... Prospective Diabetes Study 44)
@ast
A randomized double-blind tria ...... Prospective Diabetes Study 44)
@en
type
label
A randomized double-blind tria ...... Prospective Diabetes Study 44)
@ast
A randomized double-blind tria ...... Prospective Diabetes Study 44)
@en
prefLabel
A randomized double-blind tria ...... Prospective Diabetes Study 44)
@ast
A randomized double-blind tria ...... Prospective Diabetes Study 44)
@en
P2093
P356
P1433
P1476
A randomized double-blind tria ...... Prospective Diabetes Study 44)
@en
P2093
P304
P356
10.2337/DIACARE.22.6.960
P407
P577
1999-06-01T00:00:00Z